Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

This chapter outlines: (1) the reasons why epidemiologic surveys and randomized controlled clinical trials (RCTs) of diabetic polyneuropathy (DPN) are difficult and expensive, and often poorly done, (2) primary and secondary neuropathy end points, (3) single versus composite neuropathic end points, (4) adequate reference values from study of population representative cohorts, and (5) the issue of clinical proficiency.

Original languageEnglish (US)
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Pages335-338
Number of pages4
DOIs
StatePublished - Jan 1 2014

Publication series

NameHandbook of Clinical Neurology
Volume126
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Keywords

  • Polyneuropathy end points
  • Randomized controlled clinical trials
  • Standard reference values of neurophysiologic tests

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy'. Together they form a unique fingerprint.

  • Cite this

    Dyck, P. J. (2014). Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy. In Handbook of Clinical Neurology (pp. 335-338). (Handbook of Clinical Neurology; Vol. 126). Elsevier B.V.. https://doi.org/10.1016/B978-0-444-53480-4.00024-2